Covid-19 vaccine: Serum, Novavax to file for emergency use authorisation, applies to DCGI for approval

[ad_1]


SII has committed to supply 200 million doses of the Novavax vaccine between September and December 2021. Novavax said they were on track to achieve 100 million dose monthly capacity by the end of the third quarter of 2021 and 150 million dose monthly capacity by the end of the fourth quarter of 2021.

[ad_2]

Source link